Literature DB >> 2144777

Retroviral mediated transfer and expression of exogenous genes in primary lymphoid cells: assaying for a viral transactivator activity in normal and malignant cells.

R K Strair1, M Towle, P W Heald, B R Smith.   

Abstract

In this report we describe the use of recombinant retroviruses to characterize the activity of an exogenous promoter in primary cells obtained from patients with lymphoproliferative disorders. The infection of a variety of cultured and primary lymphoid cells with a recombinant retrovirus containing a histone promoter-driven beta-galactosidase gene is shown to result in the expression of beta-galactosidase in 50% to 100% of the cells. A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter, results in beta-galactosidase activity in a limited number of cultured and primary cells. Since the adenovirus E2 promoter has been well characterized and is known to be regulated by transactivators encoded by many viruses, the activity of this promoter in specific cell types is discussed in reference to both the biology of the cell and the possible presence of as yet undetected viral gene products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144777

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Functional measurement of hepatitis C virus core-specific CD8(+) T-cell responses in the livers or peripheral blood of patients by using autologous peripheral blood mononuclear cells as targets or stimulators.

Authors:  S H Fang; B L Chiang; M H Wu; H Iba; M Y Lai; P M Yang; D S Chen; L H Hwang
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Recombinant retroviral systems for the analysis of drug resistant HIV.

Authors:  R K Strair; D J Medina; C J Nelson; T A Graubert; J W Mellors
Journal:  Nucleic Acids Res       Date:  1993-10-11       Impact factor: 16.971

3.  Retroviral-mediated gene transfer in primary murine and human T-lymphocytes.

Authors:  I Rivière; H F Gallardo; A B Hagani; M Sadelain
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

4.  Use of recombinant retroviruses to characterize the activity of antiretroviral compounds.

Authors:  R K Stair; C J Nelson; J W Mellors
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.